Clinical Trials at UH-Monarch
During the past decade, UH-Monarch conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UH-Monarch"
#1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UH-Monarch
According to Clinical.Site data, the most researched conditions in "UH-Monarch" are
"Breast Cancer" (3 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "UH-Monarch" in a lesser frequency.
Clinical Trials Intervention Types at UH-Monarch
Most popular intervention types in "UH-Monarch" are "Drug" (3 trials), "Procedure" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "adjuvant therapy" (2 trials), "breast imaging study" (1 trials), "cisplatin" (1 trials), "docetaxel" (1 trials) and "erlotinib hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UH-Monarch
The vast majority of trials in "UH-Monarch" are
3 trials for "Female" genders and 2 trials for "All" genders.
Clinical Trials Status at UH-Monarch
Currently, there are NaN active trials in "UH-Monarch".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in UH-Monarch,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UH-Monarch, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".